A spatial-temporal atlas of human islet pathophysiology identifies a size-dependent trajectory from compensation to decompensation
Tengli Liu, Rui LiangiD, Lanqiu Zhang, Wenmiao Ma, Xiangyu WANG, Huixia ReniD, Shusen WangiD
Abstract
Type 2 diabetes (T2D) is characterized by progressive islet dysfunction, yet the transition from functional adaptation to failure remains poorly defined within the native tissue architecture. Using multiplex imaging mass cytometry, we systematically analyzed human pancreatic islets across a spectrum of non-diabetic (ND), prediabetic (PreD), and T2D donors, revealing that pathological remodeling is profoundly size-dependent. This remodeling is manifested as a coordinated evolution of subpopulation abundance, endocrine cell proportions, structural integrity, and protein expression profiles, revealing that islets of different sizes undergo divergent fates during disease progression. We identified a size-dependent vulnerability spectrum where medium-and large-sized islets (>100 m in diameter) serve as the primary histopathological correlates of glycemic failure (HbA1c), exhibiting early density loss and structural disintegration. In contrast, small islets (30-100 {micro}m in diameter) exhibited compensatory hormone upregulation during PreD. Notably, diverging from the death of the small paradigm in Type 1 Diabetes, our data reveal a significant expansion of extra-islet endocrine clusters (EECs) that initiates during the compensatory stage, effectively preceding the onset of overt hyperglycemia. Finally, t-SNE clustering reconstructed a continuous trajectory of islet remodeling, capturing the phenotypic evolution of islets from normoglycemia through compensation to clinical decompensation. This study provides a high-resolution atlas of islet pathophysiology, offering new insights into T2D progression. HighlightsO_LIIslet remodeling during T2D progression is critically dependent on islet size. C_LIO_LIMedium and large islets density negatively correlates with HbA1c. C_LIO_LISmall islets exhibit resilience to metabolic stress during T2D progression. C_LIO_LIEECs expansion suggests a process of -cell-biased neogenesis. C_LIO_LIt-SNE maps the islet trajectory from compensation to decompensation. C_LI
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Multi-omics profiling of living human pancreatic islet donors reveals heterogeneous beta cell trajectories toward type 2 diabetes
Leonore Wigger, Marko Barovic, … Michele Solimena·Nature MetabolismPeer-reviewed·Jun 28, 2021
- 3D imaging of human pancreas suggests islet size and endocrine composition influence their loss in type 1 diabetes
Alexandra Rippa, Amanda L. Posgai, … Mark A. Atkinson·Nature CommunicationsPeer-reviewed·Dec 11, 2025
- Organ-specific metabolic pathways distinguish prediabetes, type 2 diabetes and normal tissues
K. Diamanti, M. Cavalli, … C. Wadelius·bioRxiv·May 9, 2021
- Islet macrophages drive islet remodeling and compensatory hyperinsulinemia in the early diabetes
Manesh Chittezhath, Divya Gunaseelan, … Yusuf Ali·American Journal of Physiology-Endocrinology and MetabolismPeer-reviewed·Oct 1, 2019
- Characterization of the endocrine pancreas in Type 1 Diabetes: islet size is maintained but islet number is markedly reduced
P. Seiron, A. Wiberg, … O. Korsgren·bioRxiv·Nov 29, 2018
- Expansion microscopy reveals insulin granule clustering in human β-cells in type 2 diabetes
Licia Anna Pugliese, Valentina De Lorenzi, … Francesco Cardarelli·bioRxiv·May 8, 2026